• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性和非缺血性慢性心力衰竭患者的肾功能损害:与神经激素激活及生存率的关联

Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.

作者信息

Smilde Tom D J, Hillege Hans L, Navis Gerjan, Boomsma Frans, de Zeeuw Dick, van Veldhuisen Dirk J

机构信息

Department of Cardiology, Thoraxcenter, University Hospital, Groningen, The Netherlands.

出版信息

Am Heart J. 2004 Jul;148(1):165-72. doi: 10.1016/j.ahj.2004.02.007.

DOI:10.1016/j.ahj.2004.02.007
PMID:15215807
Abstract

BACKGROUND

Renal dysfunction is a strong predictor of mortality in chronic heart failure (CHF). Most patients with CHF have atherosclerotic vascular disease, and several authors have suggested that impaired renal function is only a marker of advanced atherosclerosis. We compared renal function in patients with ischemic and nonischemic CHF and examined associations with prognosis and extent of neurohormonal activation.

METHODS

In a large survival study (1906 patients), patients with documented coronary artery disease (CAD, n = 995), were compared with patients with idiopathic dilated cardiomyopathy (IDC, n = 429). In a smaller substudy, plasma neurohormones were determined in 270 patients and 37 patients (CAD and IDC, respectively). All patients had advanced CHF (New York Heart Association functional class III-IV). At baseline, the mean patient age was 64 +/- 10 years, and the mean left ventricular ejection fraction was 0.26 +/- 0.08. The baseline glomerular filtration rate was calculated with the Cockcroft-Gault equation (GFRc).

RESULTS

GFRc was a strong predictor for mortality in both groups on multivariate analysis. The relative risk was 3.04 for patients with IDC (P < or =.01, for the lowest quartile < or =53 mL/min), and the relative risk for patients with CAD was 1.81 (P =.01 for the lowest quartile < or =42 mL/min). Plasma neurohormones showed a relation with GFRc in both groups.

CONCLUSIONS

GFRc is related to survival and plasma neurohormones in both patient groups. In patients with IDC, this association appears to be at least as strong as in patients with CAD.

摘要

背景

肾功能不全是慢性心力衰竭(CHF)患者死亡率的强有力预测指标。大多数CHF患者患有动脉粥样硬化性血管疾病,一些作者认为肾功能受损仅是晚期动脉粥样硬化的一个标志。我们比较了缺血性和非缺血性CHF患者的肾功能,并研究了其与预后及神经激素激活程度的关系。

方法

在一项大型生存研究(1906例患者)中,将有冠状动脉疾病(CAD,n = 995)记录的患者与特发性扩张型心肌病(IDC,n = 429)患者进行比较。在一项较小的亚研究中,测定了270例患者和37例患者(分别为CAD和IDC患者)的血浆神经激素。所有患者均为晚期CHF(纽约心脏协会心功能分级III - IV级)。基线时,患者平均年龄为64±10岁,平均左心室射血分数为0.26±0.08。用Cockcroft - Gault方程计算基线肾小球滤过率(GFRc)。

结果

多因素分析显示,GFRc是两组患者死亡率的强有力预测指标。IDC患者的相对风险为3.04(最低四分位数≤53 mL/min时,P≤0.01),CAD患者的相对风险为1.81(最低四分位数≤42 mL/min时,P = 0.01)。两组患者的血浆神经激素均与GFRc相关。

结论

两组患者的GFRc均与生存率及血浆神经激素相关。在IDC患者中,这种关联似乎至少与CAD患者一样强。

相似文献

1
Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.缺血性和非缺血性慢性心力衰竭患者的肾功能损害:与神经激素激活及生存率的关联
Am Heart J. 2004 Jul;148(1):165-72. doi: 10.1016/j.ahj.2004.02.007.
2
Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
Int J Cardiol. 2006 Feb 8;107(1):73-7. doi: 10.1016/j.ijcard.2005.02.042.
3
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.静脉铁蔗糖联合促红细胞生成素治疗老年晚期慢性心力衰竭伴心肾贫血综合征的长期疗效的初步评价:对神经激素激活和临床结局的影响。
J Card Fail. 2009 Nov;15(9):727-35. doi: 10.1016/j.cardfail.2009.05.010. Epub 2009 Jun 27.
4
Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).他汀类药物治疗对非缺血性扩张型心肌病患者生存率的影响(来自β受体阻滞剂生存评估试验[BEST])
Am J Cardiol. 2007 May 15;99(10):1448-50. doi: 10.1016/j.amjcard.2006.12.080. Epub 2007 Apr 2.
5
Renal function as a predictor of prognosis in chronic heart failure.肾功能作为慢性心力衰竭预后的预测指标
Heart Fail Monit. 2002;2(3):78-84.
6
Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.缺血性或特发性扩张型心肌病所致心力衰竭中的交感神经及反射异常
Clin Sci (Lond). 2001 Aug;101(2):141-6.
7
Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery.轻度术前肾功能不全作为冠状动脉搭桥手术后长期临床结局的预测指标。
J Thorac Cardiovasc Surg. 2005 Feb;129(2):330-5. doi: 10.1016/j.jtcvs.2004.06.038.
8
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.慢性心力衰竭患者的血浆脂联素、体重指数与死亡率
Circulation. 2005 Sep 20;112(12):1756-62. doi: 10.1161/CIRCULATIONAHA.104.530972. Epub 2005 Sep 12.
9
N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.N 端前脑钠肽、肾脏疾病与慢性心力衰竭患者的预后
J Heart Lung Transplant. 2006 Sep;25(9):1135-41. doi: 10.1016/j.healun.2006.05.006. Epub 2006 Aug 2.
10
Right ventricular function predicts transplant-free survival in idiopathic dilated cardiomyopathy.右心室功能可预测特发性扩张型心肌病患者无移植生存期。
J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):706-10. doi: 10.2459/01.JCM.0000243006.90170.ce.

引用本文的文献

1
Assessment of renal congestion in a rat model with congestive heart failure using superb microvascular imaging.应用超微血流显像技术评估充血性心力衰竭大鼠模型的肾脏淤血。
J Med Ultrason (2001). 2024 Apr;51(2):159-168. doi: 10.1007/s10396-023-01396-7. Epub 2024 Jan 11.
2
Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure.硫化氢减弱肾素 - 血管紧张素和醛固酮的病理信号传导,以保护肾功能并提高心力衰竭患者的运动耐量。
JACC Basic Transl Sci. 2018 Dec 31;3(6):796-809. doi: 10.1016/j.jacbts.2018.08.011. eCollection 2018 Dec.
3
Efficacy of aliskiren supplementation for heart failure : A meta-analysis of randomized controlled trials.
阿利吉仑补充治疗心力衰竭的疗效:随机对照试验的荟萃分析。
Herz. 2019 Aug;44(5):398-404. doi: 10.1007/s00059-018-4679-1. Epub 2018 Feb 22.
4
Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.急性失代偿性心力衰竭住院患者肾功能降低的社区负担及预后影响:社区动脉粥样硬化风险(ARIC)研究社区监测
PLoS One. 2017 Aug 9;12(8):e0181373. doi: 10.1371/journal.pone.0181373. eCollection 2017.
5
Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function.心力衰竭增加肾功能正常患者发生不良肾脏结局的风险。
Circ Heart Fail. 2017 Aug;10(8). doi: 10.1161/CIRCHEARTFAILURE.116.003825.
6
Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.靶向 GPCR-Gβγ-GRK2 信号转导作为治疗心肾病变的新策略。
Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):1883-1892. doi: 10.1016/j.bbadis.2017.01.020. Epub 2017 Jan 25.
7
G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.G蛋白偶联受体-G蛋白βγ亚基信号传导介导心力衰竭中的肾功能障碍和纤维化。
J Am Soc Nephrol. 2017 Jan;28(1):197-208. doi: 10.1681/ASN.2015080852. Epub 2016 Jun 13.
8
Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review.合并慢性心力衰竭和冠状动脉疾病患者心脏不良事件的负担与预防:文献综述
Cardiovasc Ther. 2016 Jun;34(3):152-60. doi: 10.1111/1755-5922.12180.
9
Prevalence, implication, and determinants of worsening renal function after surgery for congenital heart disease.先天性心脏病手术后肾功能恶化的患病率、影响及决定因素。
Heart Vessels. 2016 Aug;31(8):1313-8. doi: 10.1007/s00380-015-0730-9. Epub 2015 Aug 13.
10
Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.肾功能损害和急性心力衰竭时肾功能恶化:新疗法是否有效?瑞那利辛的潜在作用。
Clin Res Cardiol. 2015 Aug;104(8):621-31. doi: 10.1007/s00392-015-0839-y. Epub 2015 Mar 19.